Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Filings indexed 3,371 across all filing types
Latest filing 2024-11-01 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 1% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2024-11-01 English
Monthly Return
Regulatory Filings
2024-11-01 English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2024 SECOND TRANCHE OF MEDIUM-TERM NOTES (S&T INNOVATION NOTES)
Regulatory Filings
2024-10-31 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES MHRA APPROVAL OF SUGEMALIMAB FOR FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) IN THE UK
Regulatory Filings
2024-10-31 English
CHANGE OF H SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings
2024-10-29 English
VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES PUBLICATION OF POPULATION PHARMACOKINETICS MODELLING OF CEJEMLY (SUGEMALIMAB) IN BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Regulatory Filings
2024-10-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.